Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00057135 · ClinicalTrials.gov registry record · NA

Improving Antipsychotic Adherence Among Patients With Serious Mental Illness

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT00057135: Completed NA study, sponsored by US Department of Veterans Affairs.

NCT00057135 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00057135, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

This is a randomized controlled trial examining the effectiveness of a pharmacy-based intervention designed to improve adherence with antipsychotic medications among patients with serious mental illness.

Interventions

  • BEHAVIORAL Unit of use medication packaging
  • BEHAVIORAL Mailed reminders to patient when medication refills are due
  • BEHAVIORAL Note to Mental Health Provider when refill is overdue
  • PROCEDURE Aligning all prescriptions to fall due on same date

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2002-11
Est. Completion 2006-09
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00057135 record still lists

NCT00057135 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 4 interventions - of which Unit of use medication packaging is the first listed.

NCT00057135 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00057135 about?

NCT00057135 is a clinical study titled "Improving Antipsychotic Adherence Among Patients With Serious Mental Illness". This is a randomized controlled trial examining the effectiveness of a pharmacy-based intervention designed to improve adherence with antipsychotic medications among patients with serious mental illness.

What is the current status of trial NCT00057135?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2002-11. Estimated completion is 2006-09.

What interventions are being tested in trial NCT00057135?

The interventions under investigation include: Unit of use medication packaging (BEHAVIORAL), Mailed reminders to patient when medication refills are due (BEHAVIORAL), Note to Mental Health Provider when refill is overdue (BEHAVIORAL), Aligning all prescriptions to fall due on same date (PROCEDURE).

Who is sponsoring clinical trial NCT00057135?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00057135's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00057135, the US trial registry maintained by the National Library of Medicine. NCT00057135 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.